TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-018-0351-2
PubMed Identifier: 30635634
Publication URI: http://europepmc.org/abstract/MED/30635634
Type: Journal Article/Review
Volume: 33
Parent Publication: Leukemia
Issue: 7
ISSN: 0887-6924